1. Adjuvant tyrosine kinase inhibitor therapy improves outcome for children and adolescents with acute lymphoblastic leukaemia who have an ABL‐class fusion. (14th September 2020) Authors: Moorman, Anthony V.; Schwab, Claire; Winterman, Emily; Hancock, Jerry; Castleton, Anna; Cummins, Michelle; Gibson, Brenda; Goulden, Nick; Kearns, Pam; James, Beki; Kirkwood, Amy A.; Lancaster, Donna; Madi, Mabrouk; McMillan, Andrew; Motwani, Jayashree; Norton, Alice; O'Marcaigh, Aengus; Patrick, ... Journal: British journal of haematology Issue: Volume 191:Number 5(2020) Page Start: 844 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Breakthrough bleeding episodes in pediatric severe hemophilia a patients with and without inhibitors receiving emicizumab prophylaxis: a single-center retrospective review. (15th August 2022) Authors: Hassan, Eman; Motwani, Jayashree Journal: Pediatric hematology and oncology Issue: Volume 39:Number 5(2022) Page Start: 418 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Detection of constitutional mismatch repair deficiency in children and adolescents with acute lymphoblastic leukemia. Issue 1 (2nd January 2023) Authors: Gallon, Richard; Phelps, Rachel; Betts, Leigh; Hayes, Christine; Masic, Dino; Irving, Julie A. E.; McAnulty, Ciaron; Saha, Vaskar; Vora, Ajay; Wimmer, Katharina; Motwani, Jayashree; Macartney, Christine; Burn, John; Jackson, Michael S.; Moorman, Anthony V.; Santibanez-Koref, Mauro Journal: Leukemia & lymphoma Issue: Volume 64:Issue 1(2023) Page Start: 217 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Emicizumab in previously untreated and minimally treated infants. Issue 2 (4th January 2022) Authors: Hassan, Eman; Lancashire, Jonathan; Motwani, Jayashree Journal: Haemophilia Issue: Volume 28:Issue 2(2022) Page Start: e61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Immune tolerance induction in severe haemophilia A: A UKHCDO inhibitor and paediatric working party consensus update. Issue 6 (17th August 2021) Authors: Hart, Daniel P.; Alamelu, Jayanthi; Bhatnagar, Neha; Biss, Tina; Collins, Peter W.; Hall, Georgina; Hay, Charles; Liesner, Ri; Makris, Michael; Mathias, Mary; Motwani, Jayashree; Palmer, Ben; Payne, Jeanette; Percy, Charles; Richards, Michael; Riddell, Anne; Talks, Kate; Tunstall, Oliver; Chalmer... Journal: Haemophilia Issue: Volume 27:Issue 6(2021) Page Start: 932 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Management and outcomes of paediatric patients on emicizumab prophylaxis undergoing surgical procedures: Experience from a large haemophilia centre in the UK. Issue 5 (12th June 2021) Authors: Hassan, Eman; Motwani, Jayashree Journal: Haemophilia Issue: Volume 27:Issue 5(2021) Page Start: e620 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Patients on emicizumab prophylaxis with previously tolerized inhibitors: Is there a risk of inhibitors recurrence?. Issue 2 (24th November 2021) Authors: Hassan, Eman; Lancashire, Jonathan; Motwani, Jayashree Journal: Haemophilia Issue: Volume 28:Issue 2(2022) Page Start: e36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Postauthorization safety surveillance study of antihaemophilic factor (recombinant) reconstituted in 2 mL sterile water for injection in children with haemophilia A. Issue 3 (27th April 2020) Authors: Motwani, Jayashree; Guillet, Benoit; Blatny, Jan; Schilling, Freimut H.; Wibaut, Bénédicte; Goldstine, Jimena; Nagy, Andras; Doralt, Jennifer; Engl, Werner; Tangada, Srilatha; Spotts, Gerald Journal: Haemophilia Issue: Volume 26:Issue 3(2020) Page Start: 478 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Real world experience of efficacy and safety of rivaroxaban in paediatric venous thromboembolism. Issue 221 (January 2023) Authors: Hassan, Eman; Motwani, Jayashree Journal: Thrombosis research Issue: Issue 221(2023) Page Start: 92 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Single dose Rasburicase is a clinically effective pharmacoeconomic approach for preventing tumour lysis syndrome in children with high tumour burden. (8th May 2017) Authors: Syrimi, Eleni; Gunasekera, Sanjeeva; Norton, Alice; Velangi, Mark; Motwani, Jayashree; Hiwarkar, Prashant Journal: British journal of haematology Issue: Volume 181:Number 5(2018) Page Start: 696 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗